Search

Search results

893 results found

Queer Holiday Mixer

Events: Monday, Dec 09, 2019, 11:00am -Monday, Dec 09, 2019, 01:00pm

Calling all LGBTQ+ Scientists, Postdocs, PhD Students, and Friends – Queer Holiday Mixer at Harvard Medical School Monday, December 9, 20194:00 PM – 6:00 PM Modell Center for Immunology200 Longwood Ave, Boston Join us for lots of drinks and snacks!

CANCELED: Harvard LGBTQ Leadership Conference 2020

Events: Thursday, Mar 26, 2020, 08:00pm -Friday, Mar 27, 2020, 08:00pm

For 2020, the conference’s theme is No One Left Behind, which aims to explore some of the most vulnerable LGBTQ+ communities across multidisciplinary themes. With roughly 400 expected attendees, this year’s conference presents a unique opportunity to amplify critical voices and perspectives that...

Two Common Oculoplastics Disorders

Page

Primary Acquired Nasolacrimal Duct Obstruction (PANDO) PANDO is a condition in which chronic inflammation and scarring block the tear drainage system without another identifiable cause for the obstruction, such as trauma, tumor, etc. Patients with PANDO usually seek help when tears overflow...

eye Insights Issue 10: Idiopathic Intracranial Hypertension

Page

In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). You'll find key information about how IIH is diagnosed and treated. Inside: Message from the Editor-in-Chief What is Idiopathic Intracranial Hypertension? How is a Patient Diagnosed? What are the...

Message from the Editor-in-Chief

Page

Dear Colleagues, In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). Inside, you’ll find key information about how IIH is diagnosed and treated as well as further reading. IIH is becoming more prevalent due to increasing rates of obesity in the United...

What are the Treatment Options?

Page

Acetazolamide The first-line medical therapy is acetazolamide, which reduces CSF production by the choroid plexus. In the recent IIH Treatment Trial, acetazolamide, in addition to weight loss, was found to be more effective than weight loss alone in patients with IIH and mild visual loss. The...

Don't Let Glaucoma Rob Your Patients of Vision

Page

Nearly half of Americans who currently have glaucoma are unaware of their condition. Why? Most types of glaucoma are painless, with no feelings of discomfort. Glaucoma typically affects peripheral vision first, so many people remain unaware of the disease until their central vision is affected...

MembershipForm

Link

Three-Day Temporal Bone Dissection Course Held at Mass. Eye and Ear

News: April 30, 2019

Harvard Medical School faculty members gathered last weekend for the biannual Temporal Bone Dissection Course. Directed by David H. Jung, MD, PhD, FACS, Daniel J. Lee, MD, FACS, and Michael J. McKenna, MD, this Harvard continuing medical education (CME) course brought practicing otolaryngologists up...

Mass. Eye and Ear Research Team Link Immune Cells to Uveitis

News: April 30, 2019

New research led by Kip Connor, PhD, finds that microglia—the primary immune cells of the central nervous system, including the retina—play a vital role in regulating neuroinflammation in autoimmune uveitis. The study, published in Proceedings of the National Academy of Sciences and featured on...